Medifast, Inc.

$10.92 ▲ 2.57%

2026-04-21 08:06:01

Explore Medifast, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap

$121.02 M

Current Price

$10.92

52W High / Low

$15.46 / $9.22

Stock P/E

—

Book Value

$19.29

Dividend Yield

9.97%

ROCE

-6.93%

ROE

-9.13%

Face Value

—

EPS

$-1.7

Exp Qtr EPS

—

Sector

Consumer Cyclical

Industry

Personal Services

Employees

380

Beta

0.56

Debt / Equity

5.38

Current Ratio

4.69

Quick Ratio

4.22

Forward P/E

-3.64

Price / Sales

0.29

Enterprise Value

$-52.82 M

EV / EBITDA

-1,821.29

EV / Revenue

-0.14

Rating

None

Target Price

$12

EPS Forecast (FY)

—

ABOUT

In essence, medifast, Inc., through its subsidiaries, conducts operations as a health and wellness This organization that delivers a broad range of habit-based and coach-guided lifestyle solutions to address weight loss in the United States. In essence, this organization delivers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft caters to, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. In essence, it also delivers a broad range of lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which delivers a broad range of a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In essence, in addition, This organization delivers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. In essence, it markets its products through point-of-sale transactions executed over an e-commerce platform. In essence, this organization caters to health and wellness consumers. In essence, this organization was formerly known as Healthrite, Inc. And changed its name to Medifast, Inc. In May 2001. Medifast, Inc. In essence, was incorporated in 1980 and is headquartered in Baltimore, Maryland. ROE at -9.13% based on the latest available annual data. ROCE at -6.93% using operating income and capital employed. Debt to equity stands at 0.05x. Operating margin is -10.39% on trailing numbers. Trailing twelve month sales are available in the dataset.

Pros

Balance sheet leverage appears manageable.
Short-term liquidity looks comfortable.
Valuation is not stretched on P/E basis.

Cons

Return on equity is on the weaker side.
Capital efficiency is modest.
Operating margin is thin.
Net margin is relatively low.

Sift Stocks

S.No.	Name	Price	P.E.	Market Cap	Div Yld %	ROCE	ROE	52Week High/ Low	Book Value
1.	H&R Block, Inc.	$31.71	6.67	$4.09 B	5.3%	42.13%	674.99%	$64.62 / $28.16	$-6.49
2.	Frontdoor, Inc.	$62.54	17.33	$4.39 B	—	22.99%	1.06%	$70.77 / $38.42	$3.41
3.	YY Group Holding Limited	$1.58	—	$5.03 M	—	-55.89%	-87.47%	$172.5 / $0.93	$26.73
4.	Interactive Strength Inc.	$1.1	—	$2.26 M	—	-400.4%	-3.03%	$126 / $1.03	$71.44
5.	Regis Corporation	$27.9	0.58	$68.52 M	—	4.08%	94.31%	$31.5 / $16.59	$75.52
6.	Rollins, Inc.	$54.8	50.37	$26.48 B	1.33%	30.83%	38.94%	$66.14 / $51.77	$2.86
7.	MEDIROM Healthcare Technologies Inc.	$1.2	36.3	$9.25 M	—	0.48%	53.19%	$4.45 / $0.6	$0.19

Quarterly Results

Figures shown in M / B

	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024
Sales	75.1 M	89.41 M	105.56 M	115.73 M	119 M	—
Operating Profit	-7.8 M	-4.08 M	-1.07 M	-1.26 M	0.71 M	—
Net Profit	-18.12 M	-2.26 M	2.48 M	-0.77 M	0.8 M	—
EPS in Rs	-1.64	-0.2	0.22	-0.07	0.07	—

Profit & Loss

Figures shown in M / B

	2025	2024	2023	2022
Sales	385.79 M	602.46 M	1.07 B	1.6 B
Operating Profit	-14.21 M	2.88 M	126.4 M	184.81 M
Net Profit	-18.67 M	2.09 M	99.42 M	143.57 M
EPS in Rs	-1.69	0.19	9.01	13.01

Balance Sheet

Figures shown in M / B

	2025	2024	2023	2022
Total Assets	247.97 M	284.21 M	309.91 M	316.21 M
Total Liabilities	49.05 M	74.1 M	108.43 M	161.17 M
Equity	198.92 M	210.11 M	201.48 M	155.04 M
Current Assets	201.68 M	214.4 M	224.03 M	222.78 M
Current Liabilities	42.96 M	64.16 M	92.3 M	140.89 M

Cash Flow

Last available yearly cash flow history

	2025	2024	2023	2022
Operating CF	6.86 M	24.48 M	147.66 M	194.57 M
Investing CF	-7.93 M	-26.52 M	-61.05 M	-11.41 M
Financing CF	-0.56 M	-1.51 M	-79.79 M	-199.58 M
Free CF	1.25 M	17.02 M	141.17 M	177.89 M
Capex	-5.61 M	-7.45 M	-6.48 M	-16.68 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

	2024	2023	2022	2021
Revenue Growth %	-43.8%	-32.94%	—	—
Earnings Growth %	-97.9%	-30.75%	—	—
Profit Margin %	0.35%	9.27%	8.98%	—
Operating Margin %	0.48%	11.79%	11.56%	—
Gross Margin %	73.8%	72.37%	71.34%	—
EBITDA Margin %	2.59%	13.01%	12.24%	—

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

Ex Date	Dividend
2023-09-18	$1.65
2023-06-26	$1.65
2023-03-27	$1.65
2022-12-19	$1.64
2022-09-19	$1.64
2022-06-27	$1.64
2022-03-28	$1.64
2021-12-20	$1.42
2021-09-20	$1.42
2021-06-21	$1.42

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name	Type	Shares	Value	% Out	Report Date
iShares Trust-iShares Russell 2000 ETF	Mutual Fund	0.27 M	$2.77 M	0.02%	2026-01-31
American Century ETF Trust-Avantis U.S. Small Cap Value ETF	Mutual Fund	0.18 M	$1.88 M	0.02%	2026-01-31
SCHWAB CAPITAL TRUST-Schwab Fundamental U.S. Small Company Index Fund	Mutual Fund	0.11 M	$1.15 M	0.01%	2026-01-31
iShares Trust-iShares U.S. Small-Cap Equity Factor ETF	Mutual Fund	0.1 M	$1.08 M	0.01%	2026-01-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	Mutual Fund	0.1 M	$1.06 M	0.01%	2026-01-31
iShares Trust-iShares Russell 2000 Value ETF	Mutual Fund	0.09 M	$0.94 M	0.01%	2026-01-31
Blackrock Inc.	Institutional	0.91 M	$9.48 M	0.08%	2025-12-31
Renaissance Technologies, LLC	Institutional	0.78 M	$8.09 M	0.07%	2025-12-31
Charles Schwab Investment Management, Inc.	Institutional	0.78 M	$8.05 M	0.07%	2025-12-31
Vanguard Group Inc	Institutional	0.71 M	$7.37 M	0.06%	2025-12-31
Morgan Stanley	Institutional	0.33 M	$3.47 M	0.03%	2025-12-31
Lido Advisors, LLC	Institutional	0.33 M	$3.43 M	0.03%	2025-12-31
Dimensional Fund Advisors LP	Institutional	0.33 M	$3.38 M	0.03%	2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	Mutual Fund	0.32 M	$3.3 M	0.03%	2025-12-31
Steamboat Capital Partners, Llc	Institutional	0.28 M	$2.86 M	0.03%	2025-12-31